The company was created by a group of healthcare professionals to prevent and resolve the critical problem of catheter-related infections and control the spread of hospital superbugs. The company is in discussions with a major healthcare firm and seeks to acquire a patented UV disinfection technology platform from this firm. The device developed using this platform provides high levels of disinfection at catheter penetration sites to prevent catheter-related infections. Feasibility and initial safety and efficacy studies in humans have successfully been completed.
Estimated funding required for year 1 includes $5 million to acquire patents and related intellectual property and $3 million for staffing and product development, regulatory approval, and initial marketing/sales. Admin and G&A will be held to an agreed-upon level to insure that financial targets are achieved.
The current estimated global market size for the device exceeds $1 billion with further expansion likely to address the prevention of hospital superbugs. In addition, management has identified additional product opportunities related to disposable endoscopes and cervical diagnostics. These additional products could at least double the company's projected revenues. Chairman is former CEO of a major global medical device company. Company location can be established in the US or Europe. A full business plan is available for review upon execution of an NDA.

Posted Sep 6, 2016

Did you know that social networking is a great way to buy a business? Sign up now and we'll show you how.

By clicking "Sign Up" you confirm that you accept the Terms of Use and Privacy Policy, including cookie use.

Disclaimer: MergerNetwork has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness.